Nephros Inc. Company Profile
NASDAQ: NEPHHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Nephros at a glance
Nephros Inc. (NASDAQ: NEPH) is a Medical/Dental Instruments company in the Health Care sector headquartered in South Orange, NJ. Nephros is led by Mr. Robert Banks and employs about 36 people. At a market capitalization of $28.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001196298, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Nephros do?
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- Nephros Inc.
- Ticker
- NASDAQ: NEPH
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Robert Banks
- Employees
- 36
- Headquarters
- 380 Lackawanna Place, South Orange, NJ, United States
- Phone
- 201 343 5202
- Website
- nephros.com
- Market cap
- $28.37M
- SEC CIK
- 0001196298
- Latest annual report
- 10-K/A · Apr 30, 2026
Companies similar to Nephros
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NSPRInspireMD Inc. | 0.54 | -12.97% | $29.23M | vs NEPH |
| XTNTXtant Medical Holdings Inc. | 0.21 | -2.82% | $29.49M | vs NEPH |
| TELATELA Bio Inc. | 0.6885 | -5.27% | $31.11M | vs NEPH |
| MDAISpectral AI Inc. Class A | 1.04 | -20.61% | $33.47M | vs NEPH |
| PLRZPolyrizon Ltd. | 9.31 | -8.42% | $22.61M | vs NEPH |
| DAVIDavion Healthcare Plc | 0.9001 | -9.99% | $22.50M | vs NEPH |
| SRTSSensus Healthcare Inc. | 2.26 | -4.24% | $37.20M | vs NEPH |
| PMIPicard Medical Inc. | 6.79 | +7.78% | $18.07M | vs NEPH |